Skip to content

Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver

Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01423630
Enrollment
11
Registered
2011-08-26
Start date
2011-08-31
Completion date
2022-01-04
Last updated
2022-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatty Liver

Keywords

fatty liver, probiotics, Lactobacillus, fruit, fibre, dietary intervention, obesity

Brief summary

Probiotics and fruit fibre are given for 12 weeks to patients with fatty liver disease. The hypothesis is that probiotic bacteria and fruit fibre affect the gut microbial composition in a positive manner. The improved ecological system is believed to contribute to improved liver health and thereby counteract fatty liver disease.

Interventions

DIETARY_SUPPLEMENTProbiotics and fruit fibre

probiotics and fruit fibre

Sponsors

The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)
CollaboratorOTHER_GOV
Region Skane
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* be able to participate in magnetic resonance imaging

Exclusion criteria

* unable to understand oral and written information

Design outcomes

Primary

MeasureTime frameDescription
Improved and normalized liver statusafter 12 weeks interventionnormalized concentrations of liver enzymes in plasma. Magnetic resonanse imaging (compared to magnetic resonanse imaging before intervention) will also be used in the investigation of improved liver status.

Secondary

MeasureTime frameDescription
Changes in the gut bacterial floraafter 12 weeks interventionChanges and differences of the gut bacterial flora will be addressed in detail, e.g. changes in concentration of specific bacterial groups (e.g. Lactobacillus) before and after the intervention period.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026